Derek J Maetzold Castle Biosciences Inc (CSTL) insider trading activity

Derek J Maetzold is Pres. & Chief Exec. Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 78,335 shares of CSTL, which is worth approximately $1.53 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 2,130 shares (Common Stock) at a price of $19.52 per share, resulting in proceeds of $41,577. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.3K

25.53% 3M change

8.65% 12M change

Total Value Held $1.53 Million

DEREK J MAETZOLD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2025	SELL Open market or private sale	$41,577 $19.52 p/Share	2,130 Reduced 2.65%	78,335 Common Stock
Mar 07 2025	SELL Open market or private sale	$461,835 $20.4 p/Share	22,639 Reduced 21.96%	80,465 Common Stock
Mar 04 2025	SELL Open market or private sale	$26,012 $20.86 p/Share	1,247 Reduced 1.2%	103,104 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$168,414 $22.23 p/Share	7,576 Reduced 6.77%	104,351 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	31,109 Added 21.75%	111,927 Common Stock
Jan 13 2025	SELL Open market or private sale	$28,150 $28.55 p/Share	986 Reduced 1.21%	80,818 Common Stock
Jan 07 2025	SELL Open market or private sale	$7,324 $30.14 p/Share	243 Reduced 0.3%	81,804 Common Stock
Jan 06 2025	SELL Open market or private sale	$79,386 $29.24 p/Share	2,715 Reduced 3.2%	82,047 Common Stock
Dec 17 2024	SELL Open market or private sale	$267,342 $28.55 p/Share	9,364 Reduced 9.95%	84,762 Common Stock
Dec 16 2024	SELL Open market or private sale	$318,830 $28.83 p/Share	11,059 Reduced 10.51%	94,126 Common Stock
Dec 13 2024	SELL Open market or private sale	$388,637 $28.82 p/Share	13,485 Reduced 11.36%	105,185 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$242,373 $29.63 p/Share	8,180 Reduced 6.45%	118,670 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	20,787 Added 14.28%	124,740 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$407,424 $30.91 p/Share	13,181 Reduced 11.05%	106,063 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	33,496 Added 21.93%	119,244 Common Stock
Dec 05 2024	SELL Open market or private sale	$61,822 $31.35 p/Share	1,972 Reduced 2.25%	85,748 Common Stock
Nov 12 2024	SELL Open market or private sale	$67,343 $34.15 p/Share	1,972 Reduced 2.2%	87,720 Common Stock
Nov 04 2024	SELL Open market or private sale	$64,760 $32.84 p/Share	1,972 Reduced 2.15%	89,692 Common Stock
Oct 14 2024	SELL Open market or private sale	$63,636 $32.27 p/Share	1,972 Reduced 2.11%	91,664 Common Stock
Oct 08 2024	SELL Open market or private sale	$29,846 $30.27 p/Share	986 Reduced 1.04%	93,636 Common Stock
Oct 04 2024	SELL Open market or private sale	$28,327 $28.73 p/Share	986 Reduced 1.03%	94,622 Common Stock
Sep 16 2024	SELL Open market or private sale	$61,072 $30.97 p/Share	1,972 Reduced 2.02%	95,608 Common Stock
Sep 11 2024	SELL Open market or private sale	$30,198 $30.32 p/Share	996 Reduced 1.01%	97,580 Common Stock
Sep 09 2024	SELL Open market or private sale	$29,342 $29.46 p/Share	996 Reduced 1.0%	98,576 Common Stock
Sep 04 2024	SELL Open market or private sale	$8,945 $30.02 p/Share	298 Reduced 0.3%	99,572 Common Stock

DJM

Derek J Maetzold

Pres. & Chief Exec. Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account